Jenscare Scientific Co. Ltd. Class H (HK:9877) has released an update.
Jenscare Scientific Co. Ltd. reports a 40.64% reduction in loss before tax for the first half of 2024 compared to the previous year, alongside promising developments in their cardiac device trials, including positive results for their LuX-Valve Plus and JensClip products. The company is poised to seek regulatory approval for its LuX-Valve Plus, reflecting advancements in their product pipeline and operations.
For further insights into HK:9877 stock, check out TipRanks’ Stock Analysis page.
